Diabetes risk assessment in adult population without diabetes employing continuous glucose monitoring: A novel approach
| dc.contributor.affiliation | Universidade de Santiago de Compostela. Departamento de Psiquiatría, Radioloxía, Saúde Pública, Enfermaría e Medicina | |
| dc.contributor.author | Pazos Couselo, Marcos | |
| dc.contributor.author | Lado Baleato, Óscar | |
| dc.contributor.author | Izquierdo, Verónica | |
| dc.contributor.author | Moreno Fernández, Jesús | |
| dc.contributor.author | Alonso Sampedro, Manuela | |
| dc.contributor.author | Fernández Merino, Carmen | |
| dc.contributor.author | Gude Sampedro, Francisco | |
| dc.date.accessioned | 2026-01-09T09:57:55Z | |
| dc.date.available | 2026-01-09T09:57:55Z | |
| dc.date.issued | 2025-05 | |
| dc.description.abstract | Aims Time above range obtained through continuous glucose monitoring (CGM) is a useful marker for identifying individuals at higher risk of developing diabetes. We aimed to determine the optimal cutoff for the percentage of time glucose exceeds a threshold to predict diabetes onset. Methods Prospective observational study involving CGM in individuals without diabetes. Individuals who completed CGM and were not diagnosed with diabetes at baseline were followed for a median of 10.8 years. Results Among 513 individuals (median age: 46; range: 18–82), 42 developed diabetes during follow-up. Individuals who developed diabetes were older (median age [IQR]: 53 [45–63] vs. 45 [35–57] years; p < 0.001) and had a higher BMI (32.2 [28.9–35.2] vs. 26.8 [23.8–30.3] kg/m2; p < 0.001) compared to those who did not. The most significant differences between those who developed diabetes and those who did not were observed when we set a cutoff of ≥ 130 mg/dL for at least 10 % of monitoring time. Conclusions CGM provides highly useful information for predicting type 2 diabetes. In healthy individuals, exhibiting glucose levels at or above 130 mg/dL for over 10 % of the time over at least two monitoring days show a higher risk of developing type 2 diabetes. | |
| dc.description.peerreviewed | SI | |
| dc.description.sponsorship | This study has been funded by Instituto de Salud Carlos III (ISCIII) through the project PI20/01069 and co-funded by the European Union; and the Network for Research on Chronicity, Primary Care, and Health Promotion, Instituto de Salud Carlos III (ISCIII), RD24/0005/0010, co-funded by the European Union. The Galician Innovation Agency-Competitive Benchmark Groups (GAIN-GRC/IN607A/2021/02/Xunta de Galicia) supported MA-S. This project was funded by the European Union (Programme for Research and Innovation, 2021-2027; Horizon Europe, EIC Pathfinder: 101161509-GLUCOTYPES). OL-B was granted by ISCIII Support Platforms for Clinical Research (PT23/00118/Co-funded by European Union). | |
| dc.identifier.citation | Diabetes Research and Clinical Practice Volume 226, August 2025, 112286 | |
| dc.identifier.doi | 10.1016/j.diabres.2025.112286 | |
| dc.identifier.essn | 1872-8227 | |
| dc.identifier.uri | https://hdl.handle.net/10347/44968 | |
| dc.journal.title | Diabetes Research and Clinical Practice | |
| dc.language.iso | eng | |
| dc.publisher | Elsevier | |
| dc.relation.projectID | info:eu-repo/grantAgreement/ISCIII/Programa Estatal de Generación de Conocimiento y Fortalecimiento del Sistema Español de I+D+I/PI20%2F01069/ES/IDENTIFICACION Y VALIDACION DE BIOMARCADORES PARA LA DETECCION DE INDIVIDUOS CON ALTO RIESGO DE DESARROLLAR DIABETES TIPO 2 (AEGIS-BIO) | |
| dc.relation.projectID | info:eu-repo/grantAgreement/EC/HE/101161509/EU/ | |
| dc.relation.publisherversion | https://doi.org/10.1016/j.diabres.2025.112286 | |
| dc.rights | Attribution-NonCommercial-NoDerivatives 4.0 International | en |
| dc.rights.accessRights | open access | |
| dc.rights.uri | http://creativecommons.org/licenses/by-nc-nd/4.0/ | |
| dc.subject | Continuous glucose monitoring (CGM) | |
| dc.subject | Prediction and prevention | |
| dc.subject | Incidence | |
| dc.subject | Health care | |
| dc.subject | Type 2 diabetes | |
| dc.title | Diabetes risk assessment in adult population without diabetes employing continuous glucose monitoring: A novel approach | |
| dc.type | journal article | |
| dc.type.hasVersion | AM | |
| dspace.entity.type | Publication | |
| relation.isAuthorOfPublication | 5e02c1f9-f852-484c-a325-18c6d56ee45e | |
| relation.isAuthorOfPublication | 61ef7bd7-5fc0-4694-82ef-d102c16b2204 | |
| relation.isAuthorOfPublication.latestForDiscovery | 5e02c1f9-f852-484c-a325-18c6d56ee45e |
Files
Original bundle
1 - 1 of 1